SCHEMBL12470716

SCHEMBL12470716

OC1CCN(C2CCCC[N]2)CC1

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.36
SLC18A3 Q16572 2/20 0.32
GPR119 Q8TDV5 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1428236 0.82
SCHEMBL157427 0.82 CYP2D6 (0.33)
SCHEMBL3658217 0.80 CYP2D6 (0.32)
SCHEMBL10891279 0.80 CYP2D6 (0.32)
SCHEMBL6050828 0.80 CYP2D6 (0.32)
SCHEMBL2229452 0.80 CYP2D6 (0.32)
SCHEMBL4712511 0.80 CYP2D6 (0.32)
SCHEMBL2569149 0.80 CYP2D6 (0.32)
SCHEMBL286072 0.80 CYP2D6 (0.32)
SCHEMBL8640560 0.80 CYP2D6 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2672967-A1 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR Plexxikon, Inc. (US) 2013-12-18 EP disclosed
WO-2012109075-A1 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR PLEXXIKON INC. (US) 2012-08-16 WO disclosed